featured
SGLT2 Inhibition for the Prevention of Diabetic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical journal of the American Society of Nephrology : CJASN
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
Clin J Am Soc Nephrol 2019 Nov 18;[EPub Ahead of Print], KR Tuttle, DZ CherneyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.